YEAR
- 2013.01.04 Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features. Matsubara D, Kishaba Y, Ishikawa S, Sakatani T, Oguni S, Tamura T, Hoshino H, Sugiyama Y, Endo S, Murakami Y, Aburatani H, Fukayama M, Niki T.Cancer Sci. 2013 Feb;104(2):266-73. doi: 10.1111/cas.12065
- 2013.01.04 Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin. Yumura K, Ui M, Doi H, Hamakubo T, Kodama T, Tsumoto K, Sugiyama A.Protein Sci. 2013 Feb;22(2):213-21. doi: 10.1002/pro.2203
- 2013.01.14 The early retinal progenitor-expressed gene Sox11 regulates the timing of the differentiation of retinal cells. Usui A, Mochizuki Y, Iida A, Miyauchi E, Satoh S, Sock E, Nakauchi H, Aburatani H, Murakami A, Wegner M, Watanabe S.Development. 2013 Feb;140(4):740-50. doi: 10.1242/dev.090274
- 2013.01.17 Two immunogenic passenger dendritic cell subsets in the rat liver have distinct trafficking patterns and radiosensitivities. Yu B, Ueta H, Kitazawa Y, Tanaka T, Adachi K, Kimura H, Morita M, Sawanobori Y, Qian HX, Kodama T, Matsuno K.Hepatology. 2012 Oct;56(4):1532-45. doi: 10.1002/hep.25795
- 2013.01.24 Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury. Kohno T, Urao N, Ashino T, Sudhahar V, McKinney RD, Hamakubo T, Iwanari H, Ushio-Fukai M, Fukai T.Arterioscler. Thromb. Vasc. Biol. 2013 Apr;33(4):805-13. doi: 10.1161/ATVBAHA.112.300862
- 2013.01.29 Structural and Spectral Characterization of C1C2 Channelrhodopsin and its Mutants by Molecular Simulations Kamiya, M., Kato, H.E., Ishitani, R., Nureki, O., Hayashi, S.Chem. Phys. Lett. 556, 266-71 (2013). https://doi.org/10.1016/j.cplett.2012.11.066
- 2013.03.14 Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages. Osawa T, Tsuchida R, Muramatsu M, Shimamura T, Wang F, Suehiro J, Kanki Y, Wada Y, Yuasa Y, Aburatani H, Miyano S, Minami T, Kodama T, Shibuya M.Cancer Res. 2013 May 15;73(10):3019-28. doi: 10.1158/0008-5472.CAN-12-3231
- 2013.03.20 Screening of liver-targeted drugs. Midorikawa Y, Sugiyama Y, Aburatani H.Expert Opin Drug Discov. 2008 Jun;3(6):643-54. doi: 10.1517/17460441.3.6.643
CLOSE